Singer Nicholas Jason 4
4 · Eterna Therapeutics Inc. · Filed Dec 6, 2022
Insider Transaction Report
Form 4
Singer Nicholas Jason
Director
Transactions
- Purchase
Warrants (right to buy)
2022-12-02$0.13/sh+141,644$17,706→ 141,644 total(indirect: By LLC)Exercise: $3.28From: 2023-06-02Exp: 2028-06-02→ Common Stock, par value $0.005 per share (141,644 underlying) - Purchase
Warrants (right to buy)
2022-12-02$0.13/sh+424,928$53,116→ 424,928 total(indirect: By Trust)Exercise: $3.28From: 2023-06-02Exp: 2028-06-02→ Common Stock, par value $0.005 per share (424,928 underlying) - Purchase
Common Stock
2022-12-02$3.28/sh+70,822$232,296→ 121,822 total(indirect: By LLC) - Purchase
Common Stock
2022-12-02$3.28/sh+212,464$696,882→ 266,214 total(indirect: By Trust)
Footnotes (1)
- [F1]The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.